共 26 条
[1]
Argiris A., Karamouzis M.V., Raben D., Ferris R.L., Head and neck cancer, Lancet, 371, pp. 1695-1709, (2008)
[2]
Schreiber R.D., Old L.J., Smyth M.J., Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion, Science, 331, pp. 1565-1570, (2011)
[3]
Fridman W.H., Pages F., Sautes-Fridman C., Galon J., The immune contexture in human tumours: impact on clinical outcome, Nat Rev Cancer, 12, pp. 298-306, (2012)
[4]
Ward M.J., Thirdborough S.M., Mellows T., Et al., Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer, Br J Cancer, 110, pp. 489-500, (2014)
[5]
Pages F., Berger A., Camus M., Et al., Effector memory T cells, early metastasis, and survival in colorectal cancer, N Engl J Med, 353, pp. 2654-2666, (2005)
[6]
Merlo A., Casalini P., Carcangiu M.L., Et al., FOXP3 expression and overall survival in breast cancer, J Clin Oncol, 27, pp. 1746-1752, (2009)
[7]
Gao Q., Qiu S.J., Fan J., Et al., Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection, J Clin Oncol, 25, pp. 2586-2593, (2007)
[8]
Curiel T.J., Coukos G., Zou L., Et al., Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival, Nat Med, 10, pp. 942-949, (2004)
[9]
Suzuki K., Kadota K., Sima C.S., Et al., Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor beta2 (IL-12Rbeta2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence, J Clin Oncol, 31, pp. 490-498, (2013)
[10]
Lee A.M., Clear A.J., Calaminici M., Et al., Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome, J Clin Oncol, 24, pp. 5052-5059, (2006)